195 related articles for article (PubMed ID: 15837194)
1. Same structure, different function crystal structure of the Epstein-Barr virus IL-10 bound to the soluble IL-10R1 chain.
Yoon SI; Jones BC; Logsdon NJ; Walter MR
Structure; 2005 Apr; 13(4):551-64. PubMed ID: 15837194
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of Epstein-Barr virus protein BCRF1, a homolog of cellular interleukin-10.
Zdanov A; Schalk-Hihi C; Menon S; Moore KW; Wlodawer A
J Mol Biol; 1997 May; 268(2):460-7. PubMed ID: 9159483
[TBL] [Abstract][Full Text] [Related]
3. The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor.
Liu Y; de Waal Malefyt R; Briere F; Parham C; Bridon JM; Banchereau J; Moore KW; Xu J
J Immunol; 1997 Jan; 158(2):604-13. PubMed ID: 8992974
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1.
Jones BC; Logsdon NJ; Josephson K; Cook J; Barry PA; Walter MR
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9404-9. PubMed ID: 12093920
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus IL-10 engages IL-10R1 by a two-step mechanism leading to altered signaling properties.
Yoon SI; Jones BC; Logsdon NJ; Harris BD; Kuruganti S; Walter MR
J Biol Chem; 2012 Aug; 287(32):26586-95. PubMed ID: 22692218
[TBL] [Abstract][Full Text] [Related]
6. Purification of receptor complexes of interleukin-10 stoichiometry and the importance of deglycosylation in their crystallization.
Hoover DM; Schalk-Hihi C; Chou CC; Menon S; Wlodawer A; Zdanov A
Eur J Biochem; 1999 May; 262(1):134-41. PubMed ID: 10231374
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of human interleukin-10 at 1.6 A resolution and a model of a complex with its soluble receptor.
Zdanov A; Schalk-Hihi C; Wlodawer A
Protein Sci; 1996 Oct; 5(10):1955-62. PubMed ID: 8897595
[TBL] [Abstract][Full Text] [Related]
8. Reversal of some viral IL-6 electrostatic properties compared to IL-6 contributes to a loss of alpha receptor component recruitment.
Perret D; Rousseau F; Tran V; Gascan H
Proteins; 2005 Jul; 60(1):14-26. PubMed ID: 15861391
[TBL] [Abstract][Full Text] [Related]
9. Comparison of interleukin-22 and interleukin-10 soluble receptor complexes.
Logsdon NJ; Jones BC; Josephson K; Cook J; Walter MR
J Interferon Cytokine Res; 2002 Nov; 22(11):1099-112. PubMed ID: 12513909
[TBL] [Abstract][Full Text] [Related]
10. A model of the ternary complex of interleukin-10 with its soluble receptors.
Pletnev S; Magracheva E; Wlodawer A; Zdanov A
BMC Struct Biol; 2005 Jun; 5():10. PubMed ID: 15985167
[TBL] [Abstract][Full Text] [Related]
11. Epstein Barr Virus Interleukin 10 Suppresses Anti-inflammatory Phenotype in Human Monocytes.
Jog NR; Chakravarty EF; Guthridge JM; James JA
Front Immunol; 2018; 9():2198. PubMed ID: 30356670
[TBL] [Abstract][Full Text] [Related]
12. Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity.
Toniatti C; Cabibbo A; Sporena E; Salvati AL; Cerretani M; Serafini S; Lahm A; Cortese R; Ciliberto G
EMBO J; 1996 Jun; 15(11):2726-37. PubMed ID: 8654370
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the IL-10/IL-10R1 complex reveals a shared receptor binding site.
Josephson K; Logsdon NJ; Walter MR
Immunity; 2001 Jul; 15(1):35-46. PubMed ID: 11485736
[TBL] [Abstract][Full Text] [Related]
14. Differential IL-10R1 expression plays a critical role in IL-10-mediated immune regulation.
Ding Y; Qin L; Zamarin D; Kotenko SV; Pestka S; Moore KW; Bromberg JS
J Immunol; 2001 Dec; 167(12):6884-92. PubMed ID: 11739506
[TBL] [Abstract][Full Text] [Related]
15. Noncompetitive antibody neutralization of IL-10 revealed by protein engineering and x-ray crystallography.
Josephson K; Jones BC; Walter LJ; DiGiacomo R; Indelicato SR; Walter MR
Structure; 2002 Jul; 10(7):981-7. PubMed ID: 12121653
[TBL] [Abstract][Full Text] [Related]
16. Interactions among the components of the interleukin-10 receptor complex.
Krause CD; Mei E; Mirochnitchenko O; Lavnikova N; Xie J; Jia Y; Hochstrasser RM; Pestka S
Biochem Biophys Res Commun; 2006 Feb; 340(2):377-85. PubMed ID: 16364239
[TBL] [Abstract][Full Text] [Related]
17. Expression and in vitro properties of guinea pig IL-5: comparison to human and murine orthologs.
Scott CW; Budzilowicz C; Hubbs SJ; Stein M; Sobotka-Briner C; Wilkins DE
Mediators Inflamm; 2000; 9(3-4):181-7. PubMed ID: 11132776
[TBL] [Abstract][Full Text] [Related]
18. Purification, crystallization and preliminary X-ray diffraction of a complex between IL-10 and soluble IL-10R1.
Josephson K; McPherson DT; Walter MR
Acta Crystallogr D Biol Crystallogr; 2001 Dec; 57(Pt 12):1908-11. PubMed ID: 11717514
[TBL] [Abstract][Full Text] [Related]
19. Human, viral or mutant human IL-10 expressed after local adenovirus-mediated gene transfer are equally effective in ameliorating disease pathology in a rabbit knee model of antigen-induced arthritis.
Keravala A; Lechman ER; Nash J; Mi Z; Robbins PD
Arthritis Res Ther; 2006; 8(4):R91. PubMed ID: 16704745
[TBL] [Abstract][Full Text] [Related]
20. A single amino acid determines the immunostimulatory activity of interleukin 10.
Ding Y; Qin L; Kotenko SV; Pestka S; Bromberg JS
J Exp Med; 2000 Jan; 191(2):213-24. PubMed ID: 10637267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
